An Overview on Candida auris in Healthcare Settings
Journal of Fungi · 08.09.2023 · 9 (9) · 913
DOI: 10.3390/jof9090913 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Fungi, online erschienen am 08.09.2023. Verfasst von Maria Luisa Cristina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Genoa, Via Pastore 1, 16132 Genoa, Italy. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Candida auris has become a major concern in critical care medicine due to the increasing number of immunocompromised patients and candidiasis is the most frequent cause of fungal infections. C. auris and other fungal pathogens are responsible for at least 13 million infections and 1.5 million deaths globally per year. In immunocompromised patients, infections can quickly become severe, causing wound infections, otitis and candidemia, resulting in high morbidity and mortality. The clinical presentation of C. auris is often non-specific and similar to other types of systemic infections; in addition, it is harder to identify from cultures than other, more common types of Candida spp. Some infections are particularly difficult to treat due to multi-resistance to several antifungal agents, including fluconazole (and other azoles), amphotericin B and echinocandins. This entails treatment with more drugs and at higher doses. Even after treatment for invasive infections, patients generally remain colonized for long periods, so all infection control measures must be followed during and after treatment of the C. auris infection. Screening patients for C. auris colonization enables facilities to identify individuals with C. auris colonization and to implement infection prevention and control measures. This pathogenic fungus shows an innate resilience, enabling survival and persistence in healthcare environment and the ability to rapidly colonize the patient’s skin and be easily transmitted within the healthcare setting, thus leading to a serious and prolonged outbreak.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, University of Genoa, Via Pastore 1, 16132 Genoa, Italy.
- Hospital Hygiene Unit, E.O. Ospedali Galliera, 16128 Genova, Italy.
- Infectious Disease Unit, Galliera Hospital, 16128 Genoa, Italy.
ORCID-Profile: Marina Sartini, Emanuele Pontali
Zitieren
APA
Cristina, M. L., Spagnolo, A. M., Sartini, M., Carbone, A., Oliva, M., Schinca, E., Boni, S., & Pontali, E. (2023). An Overview on Candida auris in Healthcare Settings. Journal of Fungi, 9(9), 913. https://doi.org/10.3390/jof9090913
Vancouver
Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, et al. An Overview on Candida auris in Healthcare Settings. Journal of Fungi. 2023;9(9):913. doi:10.3390/jof9090913
BibTeX
@article{Cristina2023,
author = {Cristina, Maria Luisa and Spagnolo, Anna Maria and Sartini, Marina and Carbone, Alessio and Oliva, Martino and Schinca, Elisa and Boni, Silvia and Pontali, Emanuele},
title = {An Overview on Candida auris in Healthcare Settings},
journal = {Journal of Fungi},
year = {2023},
volume = {9},
number = {9},
pages = {913},
doi = {10.3390/jof9090913}
}
EUVIMED